JP2023523323A5 - - Google Patents
Info
- Publication number
- JP2023523323A5 JP2023523323A5 JP2022565600A JP2022565600A JP2023523323A5 JP 2023523323 A5 JP2023523323 A5 JP 2023523323A5 JP 2022565600 A JP2022565600 A JP 2022565600A JP 2022565600 A JP2022565600 A JP 2022565600A JP 2023523323 A5 JP2023523323 A5 JP 2023523323A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063015883P | 2020-04-27 | 2020-04-27 | |
| US63/015,883 | 2020-04-27 | ||
| PCT/US2021/029435 WO2021222278A1 (en) | 2020-04-27 | 2021-04-27 | Methods of treating abnormal cell growth |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023523323A JP2023523323A (ja) | 2023-06-02 |
| JPWO2021222278A5 JPWO2021222278A5 (https=) | 2024-05-10 |
| JP2023523323A5 true JP2023523323A5 (https=) | 2024-05-10 |
Family
ID=78332185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565600A Pending JP2023523323A (ja) | 2020-04-27 | 2021-04-27 | 異常な細胞成長を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230201198A1 (https=) |
| EP (1) | EP4142882A4 (https=) |
| JP (1) | JP2023523323A (https=) |
| KR (1) | KR20230011277A (https=) |
| CN (1) | CN115916346A (https=) |
| AU (1) | AU2021263742A1 (https=) |
| BR (1) | BR112022021657A2 (https=) |
| CA (1) | CA3175481A1 (https=) |
| IL (1) | IL297650A (https=) |
| MX (1) | MX2022013430A (https=) |
| WO (1) | WO2021222278A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7582694B2 (ja) | 2020-01-10 | 2024-11-13 | イミューニヤリング コーポレーション | Ｍｅｋ阻害剤及びその治療的使用 |
| TW202329967A (zh) * | 2022-01-21 | 2023-08-01 | 大陸商應世生物科技（南京）有限公司 | 治療腫瘤的藥物組合及用途 |
| EP4469086A4 (en) * | 2022-01-25 | 2026-01-21 | Verastem Inc | POLYTHERAPY FOR THE TREATMENT OF ABNORMAL CELL GROWTH |
| EP4488272A4 (en) * | 2022-02-28 | 2026-02-25 | Wigen Biomedicine Tech Shanghai Co Ltd | COMPOUND USED AS A FAK INHIBITOR AND ITS USE |
| CN118973580A (zh) * | 2022-04-08 | 2024-11-15 | 米拉蒂治疗股份有限公司 | 包含sos1抑制剂和mek抑制剂的组合疗法 |
| JP2025518795A (ja) * | 2022-06-03 | 2025-06-19 | ベラステム・インコーポレーテッド | 異常な細胞成長を処置するための併用療法 |
| US11873296B2 (en) | 2022-06-07 | 2024-01-16 | Verastem, Inc. | Solid forms of a dual RAF/MEK inhibitor |
| TW202517624A (zh) * | 2023-07-03 | 2025-05-01 | 美商醫療免疫工程公司 | Mek免疫腫瘤抑制劑醫藥組合物 |
| WO2025079712A1 (ja) * | 2023-10-12 | 2025-04-17 | 中外製薬株式会社 | ドライバー変異を有するがん患者における分子標的薬併用療法 |
| WO2025261499A1 (zh) * | 2024-06-20 | 2025-12-26 | 上海科州药物股份有限公司 | 蛋白激酶Mek抑制剂苯并噻唑的颗粒药物组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN01403A (https=) * | 2009-08-24 | 2015-06-05 | Genentech Inc | |
| CA2779843A1 (en) * | 2009-11-13 | 2011-05-19 | Infinity Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| US20130217710A1 (en) * | 2010-11-05 | 2013-08-22 | Glaxosmithkline Intellectual Property (No.2) Limited | Methods for treating cancer |
| US20130004481A1 (en) * | 2011-01-12 | 2013-01-03 | Boehringer Ingelheim International Gmbh | Anticancer therapy |
| BR112017023821A2 (pt) * | 2015-05-06 | 2018-07-31 | Leidos Biomedical Res Inc | moduladores de k-ras |
| AU2018329925B2 (en) * | 2017-09-08 | 2025-05-29 | F. Hoffmann-La Roche Ag | Diagnostic and therapeutic methods for cancer |
| US11666574B2 (en) * | 2019-11-27 | 2023-06-06 | Turning Point Therapeutics, Inc. | Combination therapy involving diaryl macrocyclic compounds |
-
2021
- 2021-04-27 IL IL297650A patent/IL297650A/en unknown
- 2021-04-27 CN CN202180028579.0A patent/CN115916346A/zh active Pending
- 2021-04-27 MX MX2022013430A patent/MX2022013430A/es unknown
- 2021-04-27 CA CA3175481A patent/CA3175481A1/en active Pending
- 2021-04-27 KR KR1020227037020A patent/KR20230011277A/ko active Pending
- 2021-04-27 JP JP2022565600A patent/JP2023523323A/ja active Pending
- 2021-04-27 AU AU2021263742A patent/AU2021263742A1/en active Pending
- 2021-04-27 US US17/921,509 patent/US20230201198A1/en active Pending
- 2021-04-27 WO PCT/US2021/029435 patent/WO2021222278A1/en not_active Ceased
- 2021-04-27 EP EP21797285.0A patent/EP4142882A4/en active Pending
- 2021-04-27 BR BR112022021657A patent/BR112022021657A2/pt unknown